Cathy Eng: We have now completed 3 phase III clinical trials in a ‘rare cancer’ with EA2176 and EA2182

Cathy Eng, Co-Director of GI Oncology at the Vanderbilt-Ingram Cancer Center, shared a post on X:

”Great month for NCI CTEP Clinical Research and ECOG-ACRIN Cancer Research Group. We have now completed 3 phase III clinical trials in a ‘rare cancer’ with EA2176 and EA2182! Also our pending results of EA2165! Thank you to all providers and patients for your support!”

Source: Cathy Eng/X